News and Events

Get up to date on what Thry'vors is doing, find out about Thry'vors and thyroid cancer-related events, and check out the latest media coverage of thyroid cancer issues.

UPCOMING EVENT

Thry'vors Inc. is pleased to announce that a Patient's Forum will be held in Edmonton on June 24, 2008. The event is being co-sponsored by the Candian Thryroid Cancer Support Group (Thry'vors) Inc. and Genzyme Canada Inc. This free event is open to all thyroid cancer patients and their family members. It is a great opportunity to learn more about thyroid cancer from health care professionals.

For more information, click here to download the forum flyer.

PRESS RELEASE

Thyroid Cancer -- Growing in Incidence

Canadians' awareness of thyroid cancer needs to be improved, says the Canadian Thyroid Cancer Support Group (Thry'vors). Thyroid cancer is once again the number one cancer -- in regards to rise in incidence in Canada (with an increase of over 5% annually) according to the annual Canadian Cancer Statistics report released today. It is the fifth most prevalent cancer, and the most common cancer among young women.

While some of the rate of increase can be explained by better detection of small tumours, this increase is a world-wide phenomenon that requires the attention that other cancers garner in terms of research and patient support.

Thry'vors -- a volunteer-run organization made up of Canadian thyroid cancer survivors, provides information resources and support to individuals diagnosed with thyroid cancer.

"We have been seeing a steady increase in the number of new members joining our listserv and requesting our publications. We know that it is not only because more people are learning about our support group, it's also because more and more people are being diagnosed with thyroid cancer", says Rita Banach, the president of Thry'vors.

Although the thyroid cancer survival rate is relatively good compared to other forms of cancer, especially when detected early, thyroid cancer patients and survivors face a lifetime of monitoring and follow-up as the recurrence rate may be as high as 20%.

"The Canadian Cancer Society's annual report released today gives us a 'heads up' on what sort of increase in demand we can expect for our support services and especially for the publications that we produce and distribute to individuals and clinicians across Canada, and even in the U.S.", adds Grace Wright of Thry'vors.

Disclaimer: The information contained on this website does not constitute medical advice. Visitors are encouraged to work closely with their doctors to make sure that their individual medical needs are met. The Canadian Thyroid Cancer Support Group (Thry'vors) Inc. does not endorse any product, treatment, service or practitioner and is not responsible for the quality of the information or services offered by other organizations or websites.

© Canadian Thyroid Cancer Support Group (Thry'vors) Inc.